InsiderWatch
Try it free

Michael Halstead Insider Trades

CEO

CEO at Helus Pharma Inc.. 1 significant open-market trade reported on SEC Form 4 in the last 180 days.

On EDGAR, this filer has 62 Form 4 filings on record since 2011, the latest on Sep 21, 2026. Full history on sec.gov

$1.3M

Bought

$0

Sold

1 / 0

Buys / Sells

1

Companies

Companies

  • HELPCEO

    Helus Pharma Inc.

    1 buy, $1.3M · 2 alerts in our log

Reported Trades

Open-market transactions only (code P and S), outside any 10b5-1 plan, dated by the day the filing reached EDGAR. Each row links to the filing.

FiledCompanyTradeValue
Sep 21, 2026HELPCEObuy$1.3M

Other Insiders at These Companies

Everyone else who reported a significant open-market trade at the same company in the last 180 days. Several insiders buying at once is cluster buying.

  • Paul GlavineChief Growth Officer at HELP4 buys, $4.7M
  • Eric H. L. SoExecutive Chair at HELP3 buys, $3.6M

How to Read This Page

These are the trades an insider chose to make with their own money, not grants, option exercises or tax withholding. A purchase is the stronger signal (why buys carry more information than sales), and an insider who buys is locked out of selling for six months by the short-swing rule. The window here is 180 days; the full filing history lives on EDGAR.

Get this insider's next buy when it files

InsiderWatch reads every Form 4 as it reaches EDGAR, keeps the open-market buys that matter, and sends them by email and Telegram.

Try free for 7 days

Every alert we send is logged with its timestamp and source.